Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.92
-$0.015-0.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.27M | 32.23M | 28.69M | 26.81M | 24.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 134.25M | 125.14M | 114.50M | 100.12M | 85.74M |
| Operating Income | -134.25M | -125.14M | -114.50M | -100.12M | -85.74M |
| Income Before Tax | -126.76M | -115.86M | -104.16M | -89.98M | -76.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -126.76 | -115.86 | -104.16 | -89.98 | -76.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -126.76M | -115.86M | -104.16M | -89.98M | -76.87M |
| EBIT | -134.25M | -125.14M | -114.50M | -100.12M | -85.74M |
| EBITDA | -132.44M | -123.43M | -112.92M | -98.61M | -84.28M |
| EPS Basic | -2.54 | -2.34 | -2.15 | -1.90 | -1.71 |
| Normalized Basic EPS | -1.58 | -1.46 | -1.34 | -1.19 | -1.07 |
| EPS Diluted | -2.54 | -2.34 | -2.15 | -1.90 | -1.71 |
| Normalized Diluted EPS | -1.58 | -1.46 | -1.34 | -1.19 | -1.07 |
| Average Basic Shares Outstanding | 199.79M | 198.35M | 193.62M | 188.12M | 177.84M |
| Average Diluted Shares Outstanding | 199.79M | 198.35M | 193.62M | 188.12M | 177.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |